our new substantial shareholder is Consonance Capital Management...

our new substantial shareholder is Consonance Capital Management

here is the bio of their CEO, and MD (of the medical variety)

should know a thing or two about medical device companies


Mitchell J. Blutt, MD
CEO and Co-Portfolio Manager
Mitchell Blutt – Managing Partner & Co-Founder

Mitchell Blutt, MD is the Founder and CEO and Chairman of the Investment Committee of Consonance Capital and Consonance Capital Management and a Co-Managing Partner and Co-Founder of Consonance Capital Partners. Prior to founding Consonance Capital in 2005, he was Executive Partner at JP Morgan Partners (JPMP) from 1992 until 2004. In addition to his general management responsibilities across JPMP, Mitchell founded and led the Healthcare Group for nearly 18 years. He was one of the earliest employees at Chemical Venture Partners, the predecessor to JPMP, joining in 1987.

Mitchell currently sits on the board of directors of the Commonwealth Fund, a health policy research foundation. He is also on the Board of Overseers of the University of Pennsylvania School of Arts and Sciences. Mitchell formerly served on numerous boards of directors, including Questcor Pharmaceuticals, Cardinal Health, Cooper Holding, DJ Orthopedics, Fisher Scientific, General Medical, Hanger Orthopedic Group, Medical Arts Press, Tenax, and Thermoscan. He also formerly served on the Board of the Michael J. Fox Foundation for Parkinson’s Research, the Board of Trustees of Penn Medicine (the Health System of the University of Pennsylvania), the Board of Trustees of the University of Pennsylvania, and the Board of The Brearley School.

Mitchell is a Clinical Assistant Professor of Medicine, in the Department of Medicine at Weill Cornell Medical College and is on the New York Weill Cornell Council and the Dean’s Council of the Weil Cornell Medical College. Mitchell holds BA and MD degrees from the University of Pennsylvania. He received his MBA at the Wharton School of the University of Pennsylvania through the Clinical Scholars Fellowship sponsored by the Robert Wood Johnson Foundation. He completed his medical residency at the New York Presbyterian Hospital/Weill Cornell Medical School.